Electrical Vagal Nerve Stimulation in Ulcerative Colitis (EVASION-UC)
Electrical Vagal Nerve Stimulation in Ulcerative Colitis - a Double Blind Placebo - Controlled Study of Transcutaneous Vagal Nerve Stimulation in Ulcerative Colitis
Sponsor: Queen Mary University of London
Terminated
COVID-19
Other terminated trials from Queen Mary University of London
This NA trial investigates Transcutaneous Vagal Nerve Stimulation and Ulcerative Colitis and is currently terminated or withdrawn. Queen Mary University of London leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2022 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated · Phase: PHASE1_PHASE2 → NA
-
Feb 2021 — Apr 2022 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 2 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
May 2019 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Queen Mary University of London
For direct contact, visit the study record on ClinicalTrials.gov .